Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Phase II Study of Antineoplastons A10 and AS2-1 in Children With Brain Tumors
Brief Summary:
RATIONALE: Current therapies for childhood brain tumors provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of childhood brain tumors.
PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on children (> 6 months of age) with brain tumors.